ZOLL Medical Corporation
ZOLL Medical Corp. 別名
2012-08-08
Japan
救急救命医療関連機器の輸入・販売
着用型自動除細動器
除細動器
体温管理システム
ITソリューションシステム
X Series
R Series
LifeVest
ThermoGuard
ZOLL AED 3 BLS
AED Pro
AED 3
AED 3 AutoShock
ZOLL AED Plus
AutoPulse NXT
RescueNet CaseReview
RescueNet CodeReview
CodeMate
〒105-0003 東京都港区西新橋2丁目1番1号 興和西新橋ビル13階
田中 孝之
230,000,000  (2 億)
会社名
Group 親会社 子会社 得意先 仕入先 業務提携 銀行等 株主等
旭化成株式会社
グループ会社 親会社 子会社 得意先 仕入先 業務提携 銀行・融資・与信 出資・持分・株主
Group 親会社
グループ会社 親会社 子会社 得意先 仕入先 業務提携 銀行・融資・与信 出資・持分・株主
Group 子会社
Advanced Circulatory Systems, Inc
グループ会社 親会社 子会社 得意先 仕入先 業務提携 銀行・融資・与信 出資・持分・株主
Group 子会社
Cardiac Science社
グループ会社 親会社 子会社 得意先 仕入先 業務提携 銀行・融資・与信 出資・持分・株主
Group 子会社
Impact Instrumentation, Inc
グループ会社 親会社 子会社 得意先 仕入先 業務提携 銀行・融資・与信 出資・持分・株主
Group 子会社
Mobilize Rescue Systems™
グループ会社 親会社 子会社 得意先 仕入先 業務提携 銀行・融資・与信 出資・持分・株主
Group 子会社
Philips
グループ会社 親会社 子会社 得意先 仕入先 業務提携 銀行・融資・与信 出資・持分・株主
Group 子会社
TherOx, Inc
グループ会社 親会社 子会社 得意先 仕入先 業務提携 銀行・融資・与信 出資・持分・株主
Group 子会社
グループ会社 親会社 子会社 得意先 仕入先 業務提携 銀行・融資・与信 出資・持分・株主
株主等

121 件
日付概要
1952年 While Chief of the Cardiac Clinic at Beth Israel Hospital, Paul M. Zoll, M.D., demonstrates that external electrical stimulation of a patient's chest during cardiac arrest can produce an effective heartbeat.
1952年 ベス・イスラエル病院循環器部長(当時)のZoll博士が、体外電気的刺激が、心肺停止患者の拍動の復活に有効であることを実証。
1956年 Dr. Zoll is the first physician to successfully use external defibrillation to regulate heart rhythms in patients. This discovery contributes significantly to the decrease in heart disease mortality.
1956年 With technical collaborators, Dr. Zoll develops a way to display the heart's cardiac electrical activity on an oscilloscopic screen. This leads to the development of cardiac monitors and other programs found in modern cardiac care units.
1956年 Zoll博士が、体外除細動器を最初に臨床使用し、成功を収める。心臓の電気活動をオシロスコープに表示する手法を開発。心電計の基礎を築く。
1960年 Dr. Zoll discovers that external electrical countershock is effective in terminating supraventricular tachycardia and ventricular tachycardia. This procedure becomes widely used in the treatment of these arrhythmias and is found to be safer than administering large doses of antiarrhythmic drugs.
1964年 Dr. Zoll develops a method for long-term direct electrical heart stimulation through an implanted pacemaker.
1964年 Zoll博士が、植込み型ペースメーカーによる長期的直接心臓刺激の手法を開発。
1973年 Dr. Zoll receives the Albert Lasker Award for Clinical Medical Research, the most coveted award in medical science.
1977年 Dr. Zoll becomes Clinical Professor of Medicine, Emeritus, at Harvard Medical School.
1980年 ZOLL® is incorporated by the company's co-founders, including Dr. Zoll, Leigh Stein, and Thomas Claflin. William Bright, Chairman, and Rolf Stutz, CEO, subsequently join ZOLL.
1980年 ZOLL Medical Corporation設立
1983年 The ZOLL NTP® 1000, a non-invasive temporary pacemaker based on Dr. Zoll's research, is introduced.
1983年 非侵襲の短期ペースメーカーZOLL NTP 1000販売開始
1988年 ペースメーカー/除細動器/モニター一体型のZOLL PD 1200販売開始
1989年 Introduces adult multi-function electrodes, which provide well-tolerated pacing, effective defibrillation, cardioversion, and monitoring.
1992年 ZOLL becomes a public company.
1992年 Releases the PD 1400 pacemaker/defibrillator/monitor, the smallest device of its kind available for critical patient transport and pre-hospital treatment.
1992年 The American Heart Association elevates non-invasive pacing to the initial treatment of choice for certain serious patient conditions. ZOLL is the market leader for this technology.
1994年 Receives 510(k) marketing clearance from the FDA for the PD/D 2000 automated external defibrillator (AED)/advisory defibrillator.
1994年 AEDがFDA承認
1995年 Establishes a subsidiary in the Netherlands.
1995年 Launches ZOLL 1600, the first fully upgradeable and configurable AED/manual external defibrillator.
1995年 Introduces the first modular AC power supply/battery charger for use in hospitals on the ZOLL 1400, 1600, and 2000 family of defibrillators.
1996年 Acquires Westech Mobile Solutions, adding software-based information products to the pre-hospital product line.
1996年 Makes an equity investment in LIFECOR, Inc., a medical equipment company that makes LifeVest®, the first and only wearable defibrillator.
1996年 Introduces the ZOLL 1700, the first fully integrated AED/manual external defibrillator for basic life support (BLS) and advanced cardiac life support (ACLS) in a hospital.
1996年 Announces the new Base PowerCharger™ 4 x 4, the first system in the industry to offer a practical solution for improving the reliability, effectiveness, and cost of battery management.
1996年 LifeVestを製造する医療機器会社、Lifecore, Incへの出資を行う。
1997年 Launches RescueNet®, the only complete EMS information management system that helps improve patient care, operational efficiency, and agency compliance.
1997年 Unveils a tablet computer-based 12-lead system to help identify the onset of cardiac arrest.
1997年 救急機関向け情報管理システムRescueNetサービス開始
1998年 Introduces the M Series® monitor/defibrillator, the most advanced defibrillator worldwide. The product is approximately one-third the size and half the weight of any competitive full-featured defibrillator.
1999年 Establishes subsidiaries in Canada and Germany.
1999年 Debuts the Rectilinear Biphasic™ defibrillation waveform and is given FDA clearance to label this technology as clinically superior to monophasic defibrillators for the conversion of ventricular fibrillation in high-impedance patients and for cardioversion of atrial fibrillation.
1999年 Acquires Pinpoint Technologies to provide a complete information management solution to the EMS market.
1999年 Introduces Smart Batteries, an industry first providing users with an accurate run time display.
2001年 ZOLL establishes subsidiaries in Australia and France.
2001年 Launches the M Series CCT for critical care transport.
2001年 The ZOLL AED Plus® defibrillator is designed in cooperation with hundreds of first responders and EMS agencies.
2002年 Receives 510(k) marketing clearance from the FDA for its AED Plus defibrillator and the new CPR-D-padz® electrodes, the first system to provide instantaneous feedback on the depth and rate of chest compressions during CPR.
2002年 ZOLL provides an initial grant to help establish the AED Instructor Foundation.
2002年 ZOLL and LIFECOR, Inc. announce an agreement to sell LIFECOR's LifeVest wearable defibrillator to hospitals for patient use in the United States and Canada.
2002年 The M Series CCT is selected as the defibrillator of choice for the U.S. Military Patient Movement Item Program. The agreement, worth $8.9 million, is the single largest order in ZOLL's history.
2002年 CPRフィードバック機能付きAEDを開発
2004年 Establishes a subsidiary in Austria.
2004年 Renames its Pinpoint Technologies subsidiary ZOLL Data Systems to better reflect the EMS market.
2004年 Acquires Infusion Dynamics, Inc., which manufactures a unique fluid resuscitation product called the Power Infuser®.
2004年 Pediatric capability for the AED Plus receives clearance from the FDA.
2004年 Launches CodeNet®, the first complete data management system that solves the problem of hard-to-manage code event data for hospitals.
2005年 Introduces the ZOLL AED Pro® for professional rescuers.
2005年 Launches the E Series® monitor/defibrillator, designed to meet the specific demands and extreme conditions of the EMS environment.
2006年 Completes the acquisition of the assets of LIFECOR, Inc.
2006年 Launches the R Series® monitor/defibrillator, the first and only Code-Ready® defibrillator for hospitals.
2006年 着用型自動除細動器「LifeVest」の設計・製造・販売を行うLifecor, Inc.の買収を完了
2007年 Receives market clearance for E Series with Real CPR Help® technology.
2007年 Purchases the temperature management assets of Radiant Corporation.
2007年 Surpasses $300 million in revenues.
2007年 Receives clearance to market E Series and AED Pro with See-Thru CPR® technology whose functionality helps minimize interruptions in CPR.
2008年 STEMI solutions offer enhanced transmission technology for 12-lead ECG.
2008年 AED Pro is approved for use on MEDEVAC helicopters, receiving certification that it meets the US Defense Department’s criteria for medical devices after extensive testing by the US Army’s Aeromedical Research Laboratory.
2008年 AutoPulse approved for use in China.
2008年 LifeVest wearable defibrillator exceeds 10,000 prescriptions.
2008年 ZOLL and Welch Allyn enter strategic alliance; ZOLL becomes exclusive distributor of Propaq® LT.
2008年 Reaches $398 million in revenues, an increase of 29% over the previous year.
2009年 Purchases intravascular temperature management (IVTM™) assets from Alsius Corporation.
2009年 New R Series BLS and R Series Plus monitor/defibrillators receive FDA clearance.
2009年 Forbes誌「最も信頼できる企業Top 100」に3年連続選出(10社のみ)
2009年 Alsius Corporationより、血管内体温管理(IVTM™)事業を買収
2010年 Propaq MD monitor/defibrillator and Propaq M monitor granted clearance by the FDA.
2010年 LifeVest wearable defibrillator physician prescriptions top 30,000.
2011年 AutoPulse Circulation Improving Resuscitation Care (CIRC) trial concludes successfully; first large-scale resuscitation trial to reach a statistically significant result.
2011年 Receives Frost & Sullivan 2010 Market Leadership Award for demonstrated excellence in capturing the highest market share of the North American external defibrillator market.
2011年 PocketCPR® for iPhone – a training app – is the first to support new 2010 AHA/ERC/ILCOR Guidelines.
2011年 Reports record Q4 and annual revenues; breaks the $500 million mark with fiscal 2011 revenues of $523.7 million.
2011年 ZOLL PocketCPR
2012年 Asahi Kasei acquires ZOLL for $2.21 billion.
2012年 Introduces the first pediatric electrodes that report CPR quality on children up to eight years old.
2012年 Establishes new Japanese subsidiary Asahi Kasei ZOLL Medical (AZM).
2012年 X Series® monitor/defibrillator receives 510(k) clearance from the FDA.
2012年 旭化成株式会社がZOLL Medicalを買収
2012年 日本国内での販売子会社旭化成ゾールメディカルを設立
2013年 First medical device company to sign pledge to make real-time patient information available to clinicians, such as from EMS services to hospitals, in order to reduce preventable deaths.
2013年 Introduces the Fully Automatic AED Plus with Real CPR Help, automatically delivering a shock when it detects a shockable heart rhythm.
2014年 Expands product portfolio to include ventilation with the acquisition of assets of Impact Instrumentation, Inc.
2014年 Acquires Philips InnerCool® temperature management business.
2014年 Impact Instrumentation, Incを買収し、人工呼吸器を含め製品ポートフォリオを拡大
2014年 Philips社から体温管理システムInnerCool 事業を買収
2015年 Acquires Advanced Circulatory Systems, Inc., of Roseville, Minn., developer of the ResQPOD.
2015年 ResQCPR® system receives premarket approval from the FDA as it is shown to profoundly increase blood flow to the heart and other vital organs in pre-clinical studies.
2015年 ResQPODを開発したAdvanced Circulatory Systems, Incを買収
2016年 Receives market approval for intravascular temperature management technology to treat sudden cardiac arrest in Japan.
2016年 ZOLL AED 3® and the ZOLL AED 3 BLS automated external defibrillators are approved for marketing and distribution in Europe.
2016年 Establishment of the ZOLL EMT Scholarship, awarded to eleven caregivers in the program's inaugural year.
2017年 Health Canada approves the ZOLL AED 3 and the ZOLL AED 3 BLS automated external defibrillators for marketing and distribution in Canada.
2017年 ZOLL Hospital Wearable Defibrillator (HWD) receives premarket approval from the FDA.
2018年 Propaq M selected by U.S. Air Force and U.S. Army as their deployable vital signs monitor.
2018年 ZOLL is the first company to receive premarket approval from the FDA on its full portfolio of defibrillators.
2018年 VEST trial shows LifeVest wearable defibrillator reduces total mortality by 36% at 90 days.
2018年 Heroes for Life program launched to honor sudden cardiac arrest survivors and the "unexpected heroes" who helped save them with a ZOLL AED.
2018年 Respond™ app introduced to improve communication and navigation among EMS dispatchers, crews, and clinical staff.
2018年 Z Vent® transport ventilator introduced for pre- and intra-hospital use.
2019年 FDA approves X Series® Advanced, a monitor/defibrillator that includes Real BVM Help®, technology that provides real-time feedback on delivered ventilation rate and tidal volume. It also features TBI Dashboard™, an interface for monitoring vital signs essential to managing traumatic brain injury.
2019年 Acquires Payor Logic, Inc., a company that specializes in best-in-class accounts receivable (A/R) software solutions for the healthcare industry.
2019年 Acquires Golden Hour Data Systems, Inc. Accelerates patient charting and revenue cycle management to the EMS market.
2019年 ZOLL completes acquisition of Cardiac Science.
2019年 Acquires Mobilize Rescue Systems™, which offers interactive trauma systems to help bystanders save lives during medical emergencies.
2019年 Introduces µCor™ (pronounced "Micro Core") Heart Failure and Arrhythmia Management System (HFAMS), new technology to improve the management of acute heart failure patients.
2019年 Rebrands Payor Logic solution as ZOLL AR Boost™ to better reflect the potential impact of this technology on a wider segment of the healthcare market.
2019年 Acquires TherOx®, Inc., which offers SuperSaturated Oxygen (SSO 2) Therapy, a new FDA-approved treatment to help the most severe heart attack patients.
2019年 超過飽和酸素療法を提供するTherOx, Incを買収
2019年 緊急時の救助者による救命活動をサポートする双方向性の外傷システムMobilize Rescue Systems™を取得
2019年 Cardiac Science社の買収を完了
2020年 FDA approves next-generation TherOx system for left anterior descending ST-elevation myocardial infarction (LAD STEMI) heart attack patients.
2021年 Acquires Respicardia, Inc., a provider of novel implantable neurostimulators for the treatment of moderate to severe Central Sleep Apnea (CSA).
2021年 FDA approves next-generation rem edē® EL-X System to treat moderate to severe CSA.
2021年 Acquires Itamar Medical, a device and digital health company that provides at-home testing for sleep apnea.
2022年 ZOLL launches the Arrhythmia Management System for more informed treatment plans adding biometric data to traditional mobile cardiac telemetry information.
2022年 LifeVest has been worn by more than 1 million patients.
2024年 ZOLL significantly expands its respiratory care offerings with the acquisition of bellavista®, fabian®, LTV®, and 3100 FHO ventilator product lines from Vyaire Medical.
2025年 ZOLL launches Zenix®, an easy-to-use, highly customizable monitor/defibrillator that features groundbreaking clinical advances.
+ 開くと読み込みます
2026-07-12 00:50 (Model: ggml-org/gpt-oss-20b )
↑